Since 2007, the Health Results Innovation Trust Fund (HRITF) is supporting results-based financing (RBF) approaches in the health sector to improve maternal and child health around the world. The HRITF is supported by the Governments of Norway through Norad and the United Kingdom through the Department for International Development (DFID). It is administered by The World Bank.
As of September 2016, the total contributions to the trust fund were US$477.6 million equivalent from Norway and the United Kingdom. To date, HRITF has committed US$385.6 million for 35 RBF programs in 29 countries, linked to US$2.0 billion in financing from IDA—the World Bank’s fund for the poorest. In addition to the RBF programs, the trust fund also finances the evaluation of these programs and other supporting activities.
Since inception until June 2016, the trust fund has disbursed US$281.7 million—with 68 percent disbursed over the last three years when the majority of HRITF-funded RBF programs began implementing.
The main objectives of the HRITF are:
- Support design, implementation, monitoring and evaluation of RBF mechanisms
- Develop and disseminate the evidence base for implementing successful RBF mechanisms
- Build country institutional capacity to scale up and sustain the RBF mechanisms, with the national health strategy and system
- Attract additional financing to the health sector
With this mission, RBF approaches are being implemented to improve access to and quality of health services for women and children.
HRITF helps countries in three primary areas:
- Country Program Grants to provide financial support for design and implementation to country programs funded by the World Bank’s International Development Association (IDA).
- Knowledge and Learning Grants to support technical dialogue and learning around RBF design and implementation in IDA eligible countries.
- Evaluation Grants to support RBF program evaluation efforts to learn from successful (and unsuccessful) experiences from around the world, while contributing to local and global evidence-based policy-making.